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ABSTRACT: Molecular biology is providing opportunities to develop new strategies or agents for the treatment of a wide vari-
ety of diseases. The availability of large amounts of highly purified proteins produced by recombinant DNA techniques is an
obvious example. Recent evidence has implicated proteins belonging to the bone morphogenetic protein (BMP) subgroup of
the transforming growth factor beta supergene family in tooth formation and dentinogenesis. It has long been known that bone
and dentin contain bone morphogenetic protein activity. Recently, recombinant human BMP-2, -4, and -7 (also known as OP-
1) have been shown to induce reparative dentin formation in experimental models of large direct pulp exposures in permanent
teeth. The manner in which these agents act appears unique. New reparative dentin replaces the stimulating agents applied
directly to the partially amputated pulp. Hence, the new tissue forms contiguous with, largely superficial to, and not at the
expense of the remaining vital pulp tissue. This suggests a therapeutic approach permitting the induction of a predetermined
and controlled amount of reparative dentin. Additionally, OP-1 has been associated with the formation of reparative dentin
after application to a freshly cut but intact layer of dentin. These findings may provide future clinicians with additional options
for the treatment of substantially damaged or diseased vital teeth.
Keywords. Bone morphogenetic proteins, reparative dentin, reactionary dentin, odontoblast differentiation.
(I) Introduction
V ital pulp therapy may be broadly defined as anyaspect of restorative dental treatment intended to
minimize trauma to the dental pulp. More specifically, it
may refer to those procedures intended to protect the
pulp, in the absence of exposure, from phlogistic or toxic
effects of dental materials, or microbiological, thermal,
and mechanical damage. These procedures typically
involve the use of cavity liners and bases. Vital pulp ther-
apy may also involve the transdentinal (indirect) and
direct stimulation of tertiary dentin matrix formation in
and by vital dental pulps. Materials or agents used to
stimulate the formation of such tertiary dentin matrices
may be categorized as non-biologic (physical, chemical,
etc.) or biologic, based upon the nature of the therapeu-
tic material. Here, we focus on biologic agents—com-
pounds synthesized in and by biological systems.
Calcium hydroxide, cyanoacrylates, dental cements such
as zinc oxide or phosphate preparations, and similar
materials are, under this definition, non-biologic and
therefore are not reviewed. Reviews and textbook chap-
ters covering such agents are available; for example, see
Glass and Zander (1949), Hess (1950), Haskell et al.
(1978), Seltzer (1988), Stanley (1989), and the references
therein. Most studies in this area have dealt with the
preservation of pulp vitality and stimulation of tertiary
dentin matrices as coupled biological phenomena. The
repair or regeneration of pulp tissue is usually consid-
ered in combination with dentinogenesis and not as a
therapeutic goal unto itself. This is a logical extension of
the concept of the dentin-pulp complex as an integral
structural and functional unit. Therefore, much of the
current data is interpreted from this perspective. Success
for most experiments is defined in the context of forma-
tion of new tertiary dentin matrices. Materials such as
hard-set calcium hydroxide are described as giving rise
to dentin formation within or at the expense of the pulp
tissue. Hence, such reparative dentin is described as
reducing the size of the pulp chamber deep to the
remaining layer of the therapeutic material. Evidence
from recent experiments using recombinant human pro-
teins in direct pulp exposures suggests that a new para-
digm may soon emerge (data reviewed below). In this
paradigm, the therapeutic agent induces its own replace-
ment with a fibrous connective tissue reminiscent of
immature pulp that subsequently mineralizes, leaving a
mass of reparative dentin in situ. This reparative dentin
forms superficial to and not at the expense of the pulp
tissue.
Confusion exists regarding the categorization of ter-
tiary dentin matrices. The term "osteodentin", a form of
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dentin found in primitive fish (Orvig, 1967), is often
applied to mammalian tertiary dentin, which, due pri-
marily to the presence of cells surrounded by mineral-
ized matrix, superficially resembles bone at the level of
resolution of the light microscope. When referring to ter-
tiary dentin matrices of mammalian teeth, we prefer to
use the terms Separative" or "reactionary" dentin (Lesot
etal, 1993). By these definitions, the distinction between
reparative and reactionary dentin is based upon the ori-
gin of the odontoblasts responsible for its production.
Reparative dentin is a tertiary dentin matrix formed by
new odontoblast-like cells in response to a specific stim-
ulus, while reactionary dentin is formed by surviving
odontoblasts subjacent to diseased or otherwise dam-
aged dentin. This focus on the nature and activity of the
cells responsible for the production of the tertiary dentin
matrix is both theoretically and practically useful.
Different biologically based strategies for the therapeutic
induction of each type of tertiary dentin may necessarily
be predicated upon the nature of available cells capable
of responding to the initial stimulus.
An excellent review of dentinogenesis has recently
been published (Linde and Goldberg, 1993).
Dentinogenesis in adult teeth following loss of odonto-
blasts or the partial amputation of pulp tissue has been
reviewed (Baume, 1980). Lesot and colleagues (Lesot et
al, 1993) reviewed recent experimental approaches to
the induction of odontoblast differentiation with regard
to reparative and reactionary dentinogenesis.
Information pertaining to biologically based approaches
to vital pulp therapy intersects at least partially with that
pertaining to odontoblast differentiation. Therefore, we
attempt to build upon this subject by reviewing relevant
new data from the perspective of whether the clinical
access to the vital pulp is direct or transdentinal. The
search for biological dentinogenic molecules has most
recently focused on bone and dentin matrices. Literature
published and indexed as of February, 1995, has been
surveyed.
(II) Biological Dentinogenic Molecules:
Non-diffusible Extracellular Matrix Proteins
COLLAGEN
The rationale for the use of collagen to induce bone or
dentin formation was provided by evidence documenting
that biological mineral formation initiates within colla-
gen fibers and conjecture that collagen gels may provide
an appropriate scaffolding for tissue formation. In this
regard, native collagen gels were not as efficacious as
calcium hydroxide in promoting pulp repair and repara-
tive dentin formation in rats (Johannson et al, 1963).
Similar results were observed in dog pulp exposures
treated with xenogenic, acid-soluble, collagen-enriched
solutions which had been enzymatically treated to
reduce antigenicity (Carmichael et al, 1974), xenogenic
collagen sponges, or other types of collagen prepara-
tions (Dick and Carmichael, 1980).
Substantial formation of pulp without reparative
dentin formed in 30 days in experimental dog pulpal
wounds treated with direct application of an enriched,
acid-soluble autologous skin collagen solution
(Bimstein and Shoshan, 1981). A similar preparation of
monkey skin collagen was associated with pulpal healing
60 days after direct application to exposed pulps in
pulpotomized monkey teeth. Dentin bridges were evi-
dent in some anterior teeth. Pulp tissue was present
superficial to zones of reparative dentin, suggesting that
this collagen solution induced the formation of a pulp-
like tissue and that further mineralization of the new tis-
sue might occur. Since only one healing interval was
evaluated, no evidence regarding the initial development
or fate of this tissue is available (Fuks et al, 1984). In a
follow-up study, a commercial preparation of collagen
was associated with pulpal inflammation and necrosis
(Fuks et al, 1991). These studies suggest that naturally
sourced collagen, alone, is currently not a promising
material for biological approaches to vital pulp therapy.
Since no further studies are available, many questions
regarding the efficacy and safety of collagen preparations
remain unanswered.
FlBRONECTIN
Another approach to therapeutic dentinogenesis in
direct pulp exposures is to provide an organizing surface
or substrate in substitution for the basement membrane.
Dental papilla cells attach to a basement membrane
prior to terminal differentiation into odontoblasts
(ThesleffandHurmerinta, 1981; Kollar, 1983; Ruch, 1985).
Cell attachment factors such as fibronectin were sug-
gested (Veis, 1985). Fibronectin or type I collagen in vitro
failed to induce odontoblast elongation and polarization
(Lesot et al, 1985), but in combination with transforming
growth factor [}, (TGF-pn was associated with the initia-
tion of odontoblast differentiation in dental papilla cell
cultures (Lesot et al, 1993). Atubular and tubular dentin
formation occurred on bovine plasma fibronectin-coated
Millipore filters four weeks after implantation of the fil-
ters in dog pulps (Tziafas et al, 1992a). Whereas these
data suggest that xenogenic fibronectin may be associat-
ed with induction of reparative dentinogenesis, an
atubular matrix formed in contact with the membrane
while tubular dentin appeared limited to the surface of
the newly formed atubular matrix. The authors suggest
that the absorption of autologous molecules to the ini-
tial matrix may be a factor influencing the subsequent
pattern of mineralized matrix formation. A pattern of ter-
tiary matrix formation where tubular dentin forms on the
surface of atubular dentin has been repeated in other
models of reparative dentinogenesis (Nakashima, 1990,
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1994; Tziafas and Kolokuris, 1990; Rutherford et al, 1993,
1994), discussed below.
DIFFUSIBLE EXTRACELLULAR MATRIX MOLECULES:
GROWTH FACTORS
Demineralized dentin powder induces ectopic bone for-
mation (Bang and Urist, 1967a,b; Yeomans and Urist,
1967; Huggins and Urist, 1970; Urist, 1971; Bang, 1972,
1973; Bang and Johannessen, 1972; Bang et al, 1972;
Inoue et al, 1986). These studies were stimulated by
Marshall Urist's seminal demonstration of the in vivo
ectopic osteogenic activity of demineralized bone pow-
der (Urist, 1965). The subsequent search for the mole-
cules in bone responsible for osteogenic activity led to
the cloning of genes coding for some of the osteogenic
(bone morphogenetic) proteins (Wozney et al, 1988;
Ozkaynak etal, 1990, 1992). Bone (Hauschka et al, 1986)
and dentin (Finkleman et al, 1990) matrices also contain
several other biologically active molecules.
Osteogenic (OP) or bone morphogenetic (BMP) pro-
teins comprise a subgroup of a larger family of struc-
turally related proteins, designated the TGF-p superfam-
ily, and are implicated in diverse biological activities
involving differentiation, tissue morphogenesis, regener-
ation, and repair. Eight members of the BMP subfamily
have been identified: BMP-2, -3, -4, -5, -6 (Wozney et al,
1988; Celeste etal, 1990), andOP-1, -2, and-3 (Ozkaynak
et al, 1990, 1992). OP-1 and -2 are also known as BMP-7
and -8. Like other members of the TGF-P family of pro-
teins, the BMPs are synthesized and secreted as large
precursors from which a large peptide (pro-domain) is
subsequently cleaved to form the mature carboxy-termi-
nal, dimeric, signaling molecule (Massague, 1990). No
biological functions have been assigned to the large
monomeric pro-domain, which is thought to be cleaved
during or immediately after secretion by cells in vitro
(Fig.). Recombinant BMP-2, -4, -5 (Wozney, 1992), and
OP-1 (Sampath and Rueger, 1994) induce intra- and
extraskeletal bone formation.
Dentin fragments introduced into pulp during
mechanical exposure or implanted demineralized dentin
induces mineralized tissue formation (Anneroth and
Bang, 1972; Seltzer and Bender, 1984). The dentin-asso-
ciated activity can be partially removed by extraction
with 4 M guanidine-HCL, suggesting that dentin matrices
possess an extractable dentinogenic activity (Nakashima
1989). Extracellular matrix (ECM) deposition onto the
implanted demineralized dentin surface preceded mor-
phological evidence of cell differentiation toward odon-
toblast-like cells.
Autologous demineralized dentin chips experimen-
tally implanted into dog dental pulps were covered with,
first, a layer of atubular matrix, followed by a layer of
tubular-like predentin and associated odontoblast-like
cells (Tziafas and Kolokuris, 1990). In no case was tubu-
lar-like dentin deposited directly onto the implanted
chips. In a short-term follow-up study, the effects of
autologous demineralizd and non-demineralized dentin
chips implanted into dog pulps (Tziafas etal, 1992b) were
compared. The non-demineralized chips were prepared
to possess both dentin and predentin surfaces. No inac-
tive control materials were compared. Only the predentin
surface was associated close to new odontoblast-like
cells, while demineralized or non-demineralized dentin
was associated with the formation of new extracellular
matrix before the appearance of odontoblast-like cells
occurred. Attachment proteins, such as fibronectin,
adhering to the dentin matrix were suggested to mediate
cell differentiation; however, the data do not support
such speculation.
These studies are interpreted to suggest that dentin
is capable of inducing the production of tertiary dentin-
like matrices when implanted into dental pulps. No
quantitation or statistical analyses are included. It would
be of interest to know: (1) the proportions of successes
and failures, (2) the relative potency of denaturant
extracted and non-extracted demineralized dentin, and
(3) an estimate of the variability of the tissue response to
the several preparations.
The observations that non-collagenous proteins
with bone morphogenetic protein (BMP)-like activity
could be isolated from dentin matrix (Butler et al, 1977;
Conover and Urist, 1982; Mera, 1988; Bessho et al, 1990)
indicated that at least some members of the BMP family
of proteins may be involved in tooth development and
dentinogenesis. Similar suggestions have been made for
TGF-p and IGF-I and -II (SGF-II), since these molecules,
present in bone extracellular matrix, have also been
detected in adult dentin (Finkleman et al, 1990).
However, dentin extracts with BMP activity have not been
further characterized. Additional data suggesting that
IGF-I, TGF-p123, and some of the BMPs (Table) are
involved in tooth development were initially suggested
by immunolocalization or in situ hybridization analyses of
embryonic tooth development (Heine etal, 1987; Lehnert
and Akhurst, 1988; Lyons et al, 1990; Pelton et al, 1990;
Joseph etal, 1993).
TGF-pj 3 mRNA and proteins are expressed at vari-
ous stages in developing teeth (Heine et al, 1987;
Lehnert and Akhurst, 1988; Pelton et al, 1990; Vaahtokari
et al, 1991; lepsen et al, 1992; Heikinheimo et al, 1993;
Begue-Kirn et al, 1994). One important observation from
these studies is that frequently m-RNA and protein are
not co-expressed. This differential expression may reveal
clues regarding the mechanisms whereby a growth factor
or morphogen influences tissue formation (e.g.,
autocrine vs. paracrine). Protein association with a tissue
distinct from that synthesizing the m-RNA could reflect
the distribution of receptors for that protein or other
mechanisms for tissue-specific distribution of soluble
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factors. However, normal tooth devel-
opment and eruption in a TGF-fJ,
knockout (TGF-pjTTGF-p,-) mouse
(D'Souza et al, 1995) suggest that
fetal expression of this gene is not
essential for normal tooth develop-
ment. It is possible that maternal
proteins or other fetal genes provide
the necessary functions.
In the mouse, BMP-2 mRNA is
expressed first in the inner enamel
epithelium, then (E16) in dental mes-
enchyme and later in odontoblasts
during late bell stage (Lyons et al,
1990; Vainio eta!., 1993). BMP-2 mRNA
in human fetal tooth buds, detected
by the reverse transcriptase-poly-
merase chain reaction, was temporal-
ly correlated with odontoblasts only
after formation of primary dentin
matrix and not earlier during cap and
bell stages (Heikinheimo, 1994). In
mice, the pattern of BMP-4 expression
differs both temporally and spatially
from that of BMP-2 (Vainio et al, 1993). BMP-4 mRNA
expression is first detected in association with the initial
epithelial thickenings marking that epithelium which sub-
sequently invaginates into subjacent mesenchyme. Later,
it is transiently expressed in both the epithelium and the
condensing mesenchyme, where expression is limited to
those areas occupied by pre-odontoblasts. Transient
expression is then associated with the enamel epithelium
prior to ameloblast differentiation. BMP-4 expression was
related to the pattern of reciprocal epithelial-mesenchy-
mal interactions (EMI) proposed to mediate inductive
interactions (Vainio et al, 1993) which appear to function
in tooth formation (Kollar, 1983). BMP-4 induces the
expression of the homeobox-related genes Msx-1 and
Msx-2 (Vainio et al, 1993) which are expressed during
(MacKenzie et al, 1991, 1992; Jowett et al, 1993) and may
function in tooth development (Satokata and Maas,
1994). In contrast, BMP-4 was not detected in an earlier
study of mouse tooth development ((ones et al, 1991),
and BMP-4 mRNA expression in developing human tooth
buds was restricted to the dental papilla throughout cap
and bell stages, while osteoblasts of the surrounding
alveolar bone continuously expressed BMP-2 and -4
mRNA (Heikinheimo, 1994).
In human tooth buds, BMP-6 protein was immunolo-
calized to the enamel epithelium during cap-stage shift-
ing to the dental papilla during the bell stages and was
predominantly but not exclusively expressed by odonto-
blasts at the time of mineralization. This pattern of
expression is proposed as consistent with a role in EMI
(Heikinheimo, 1994). Similarly, OP-1 has been
Figure. Osteogenic protein-1 (BMP-7). Schematic diagram of OP-1. The prodomain is
cleaved during or just after secretion by cells in vitro. The extent of sequence identity
among the various BMP proteins is less in this domain than in the cleaved signaling mol-
ecule which contains the canonical TGF-p domain. The signaling molecule is associated
with the known biologic activities.
immunolocalized to the basement membrane of the den-
tal lamina and later, as the dentin matrix forms, to odon-
toblasts (Valecillos et al, 1993). Given the high degree
(70-80%) of sequence identity between BMP-6 and OP-1
(Celeste etal, 1990), it will be necessary to rule out cross-
reactivity between the anti-OP-1 antibody and BMP-6 to
confirm OP-1 expression. The anti-BMP-6 antisera used
in these studies failed to detect OP-1 (BMP-7) produced
in vitro Wall etal, 1993).
BMP-6 immunolocalization appeared to be limited
to the cytoplasm of the immuno-positive cells
(Heikinheimo, 1994). The anti-BMP-6 antibody used in
this study was raised against the pro-domain peptide
(Fig.) of the molecule to limit the potential for cross-
reactivity to BMP-5 and OP-1, since this domain has the
lowest level of sequence identity (Celeste et al, 1990). In
studies of BMP-6 protein expression, the data suggest
that the predominant form of the molecule immunode-
tected in steady-state protein in vivo is the pro-domain of
the cleaved molecule. The antibody immunoprecipitated
the cleaved signal protein (Fig.), but it failed to detect
this form in Western blots (Wall et al, 1993). The presence
of detectable amounts of immunoreactive BMP-6
polypeptide in the cytoplasm of odontoblasts, papilla
cells, osteoblasts, and pre-ameloblasts (Heikinheimo,
1994) suggests that the pro-domain accumulates intra-
cellularly. This could mean that the cleaved pro-domain
(Fig.) functions intracellularly independently of the
remainder of the molecule. Absence of a clear demon-
stration of the signaling form (Fig.) of BMP-6 in these
studies weakens the case for a role of BMP-6 in EMI dur-
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ing tooth formation.
Further evidence of a role of IGF-I, TGF-p, BMP-2,
and a non-collagenous extract from dentin matrix (which
may contain these as well as other molecules (Finkleman
et al, 1990) in tooth development has been published
(Begue-Kirn et al, 1992, 1994). These studies revealed
that a non-collagenous dentin extract (Smith et al, 1990)
induced odontoblast differentiation in mouse papilla
cultures. This activity was inhibited by pre-incubation
with anti-TGF-pj and anti~TGF-p2 antibodies, suggesting
that growth factors known to exist in dentin matrix could
induce odontoblast differentiation (Begue-Kirn et al,
1992). Subsequently, these investigators have shown
that combinations of TGF-Pj and heparin, IGF-I and BMP-
2, and IGF-1 and TGF-p, mimicked the effect of the dentin
matrix extract on odontoblast differentiation in vitro.
However, different patterns of gene expression were
detected in odontoblasts developing in vitro and in vivo
(Begue-Kirn et al, 1994). Data regarding expression of
TGF-p superfamily genes in developing teeth are sum-
marized in the Table.
Cultured human adult pulp cells derived from a sin-
gle human adult pulp were recently reported to contain
BMP-2, -4, and -6 mRNA (Takeda et al, 1994).
Immortalized mouse papilla cells express BMP-2, -4, and
OP-1 mRNA (Mary MacDougal, personal communica-
tion). We have cloned cDNAs for BMP-2, -4, and OP-1
from RNA prepared from human pulps and human pulp
cells in culture by the reverse transcriptase-polymerase
chain reaction. The primers, unique to each gene,
defined a region which spanned known exon splice sites,
ruling out amplification of genomic DNA which may con-
taminate total cell RNA preparations. Identity of the
cDNAs was confirmed by sequencing (R.B. Rutherford,
unpublished observations). Hence, it appears that cul-
turing pulp cells does not alter expression of these
genes. Given the heterogenous cell populations which
comprise the dental pulp and the fibroblastic appear-
ance of those cells which grow from explants, it will be of
interest to determine which pulp cells express these
genes and to study the regulation of expression. It will
also be important to determine which (if any) cells of
adult pulps produce each protein, because BMP mRNA
expression is not perfectly correlated with the detection
of protein (Wailful., 1993).
These data suggest that several members of the TGF-
p supergene family (TGF-p, 23, BMP-2, -4, -6, and OP-1)
and IGF-I may play multiple roles during tooth develop-
ment. These roles could include mediating epithelial-
mesenchymal interactions, odontoblast differentiation,
and dentinogenesis and facilitating tooth eruption. TGF-
p and IGF-I and -II (Finkleman et al, 1990) as well as a
molecule(s) with BMP activity are present in dentin. Low
levels of at least some of these mRNAs are present in
adult pulps, suggesting that the proteins may be
inducible or constitutively synthesized. Finkleman and
co-workers speculate that caries may release biologically
active molecules from dentin which stimulate the forma-
tion of reactionary or reparative dentin (Finkleman et al,
1990). It will be interesting to determine the effects of
these molecules on odontoblast differentiation, gene
expression, protein synthesis, and, ultimately, the pro-
duction of a mineralized dentin matrix.
Most of the evidence implicating growth factors in
tooth development is circumstantial and incomplete. In
addition, great care must be exercised in the interpreta-
tion of studies utilizing in situ hybridization which fail to
utilize control sense as well as antisense riboprobes.
Interpretation of the specificity of the proposed patterns
of expression is more difficult without such control data.
Because substantial regions of the BMP nucleic acid and
protein sequences are identical or nearly so (Fig.), the
regions of the molecules from which cDNAs for ribo-
probe preparation are derived must be carefully selected
to minimize cross-hybridization. Riboprobes prepared by
reverse transcription of specific cDNAs are routinely
hydrolyzed to approximately 200 bp before in situ
hybridization. This may increase the chances of cross-
hybridization. Similarly, the extent to which antibodies
to the different proteins cross-react must be determined
before definitive claims implicating a specific gene prod-
uct may be made. It is also important to note that
expression of an mRNA does not necessarily establish
that physiologically significant amounts of the protein
are produced (Wall et al, 1993).
(Ill) Reparative Dentinogenesis—
Direct Approach
The data reviewed above have inspired and stimulated
current efforts to study biological approaches to the
preservation of pulp vitality and direct stimulation of
reparative dentin formation. Most recently, this work has
focused on BMP-2 and -4, OP-1, TGF-p, and platelet-
derived growth factor (PDGF). The first study demon-
strated that a solubilized, unpurified preparation from
allogenic dentin which possessed BMP activity stimulat-
ed reparative dentinogenesis in partially amputated
pulps of adult dog teeth (Nakashima, 1990). The replace-
ment of the implant with a loose fibrous connective tis-
sue and a small amount of an atubular tertiary matrix
with cellular inclusions occurred by one month. By two
months, approximately half of this tissue was replaced
with atubular and associated tubular-like reparative
dentin. Very little reparative dentin formed in the control
albumin-treated teeth. A qualitatively similar result from
use of a crude xenogenic bone-derived BMP preparation
was subsequently described (Lianjia et al, 1993). The
crude dentin or bone extracts with BMP activity could
contain other active factors (Finkleman et al, 1990; Smith
et al, 1990), confounding identification of dentinogenic
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agents.
Smith and co-workers described the capacity of a
crude dentin preparation extracted by EDTA and collage-
nase digestion to stimulate reparative dentinogenesis in
small pulp exposures in ferrets (Smith et al, 1990). The
active factor(s) was not identified, but the capacity of this
dentin extract to influence odontoblast differentiation in
vitro was inhibited by anti-TGF-f^ and anti-TGF-(32 antis-
era as described above (Begue-Kirn et al, 1992).
In a follow-up study to her previous work,
Nakashima reported that recombinant human BMP-2
and -4, but not TGF-(3, induce reparative dentinogenesis
in dogs when placed on partially amputated dental pulps
(Nakashima, 1994). Similar data from non-human pri-
mate studies using recombinant human OP-1 have been
reported (Rutherford et al, 1993, 1994). The selection of
recombinant human OP-1 for use in these dentinogene-
sis experiments was predicated upon data derived from
experiments with bone, since the specific protein(s)
responsible for the BMP activity in dentin has not been
identified. OP-1 and, to a lesser extent, BMP-2 were
shown to account for most of the extractable BMP activ-
ity (Sampath et al, 1990). In addition, OP-1 (BMP-7) may
be substantially more potent than BMP-2 (Wang et al,
1990). The OP-1 studies demonstrate that:
(1) OP-1, but not PDGF, complexed with an insolu-
ble collagen delivery vehicle (CM) predictably
and reliably induces reparative dentinogenesis
in non-human primates;
(2) the initial response appeared to be a fibroblas-
tic and angiogenic invasion of the OP-I/CM,
resulting in a mineralizing mass of new pulp tis-
sue which forms largely superficial to and not at
the expense of existing pulp tissue;
(3) the amount of reparative dentin formed was
proportional to the total mass of OP-I/CM
placed on the freshly amputated pulp;
(4) OP- I/CM reparative dentin formation appeared
to be independent of the amount of coronal or
radicular pulp removed;
(5) mineralized matrix constituted 95% of the
reparative dentin by six months in monkeys;
and
(6) OP-1/CM-induced reparative dentin is initially
predominantly atubular, with odontoblast-like
cells associated with areas of tubular-like
dentin appearing by one month.
Type 1 collagen from bovine bone was used as the
carrier of recombinant human OP-1 in the primate model
of reparative dentin formation (Rutherford et al, 1993,
1994). This carrier is bone powder which has been dem-
ineralized, sieved, extensively extracted with quanidine
hydrochloride, washed in water, and lyophilized
(Sampath and Reddi, 1981). In contrast, Nakashima used
dog dentin prepared similarly and mixed with chon-
droitin 6-sulfate and acid-soluble rat tail tendon colla-
gen (Nakashima, 1994). Addition of recombinant BMP-2
and -4 to this dentin-derived collagen approximately
doubled (82% vs. 42%) the amount of reparative dentin
formed during a 60-day healing period in dog permanent
teeth (Nakashima, 1994). In contrast, the bovine-derived
collagen carrier was uniformly, totally inactive with
regard to reparative dentin formation in primates over
the six-month healing interval (Rutherford et al, 1993,
1994). Approximately 30% of all carrier-treated teeth had
at least partially vital but inflamed pulps after 30-180
days (R.B. Rutherford, unpublished data). These differ-
ences in response to the carrier could be related to dif-
ferences in the source of the collagen, the methods of
preparation (Nakashima, 1989; Sampath et al, 1990), the
size of the defect, or the animal model (dogs vs. mon-
keys).
These data demonstrate that reparative dentin forms
in response to recombinant BMP-2 and -4 and OP-1. The
tissue initially appears atubular, with cellular and soft-
tissue inclusions. Subsequently, a more tubular form of
matrix with associated odontoblast-like cells appears
attached to the mass of atubular matrix. This is similar to
the pattern of tissue formation occurring in response to
implanted dentin chips (Tziafas and Kolokuris, 1990;
Tziafas et al, 1992b) and fibronectin-coated filters
(Tziafas et al, 1992b). This observation supports the idea
that some extracellular structure is a prerequisite to
odontoblast differentiation and tubular dentin formation
(Kollar, 1983; Veis, 1985) and implicates atubular dentin
in that role.
FUTURE DIRECTIONS
The animal-efficacy or proof-of-principle experiments
described (Nakashima, 1990, 1994; Rutherford etal, 1993,
1994) above raise several interesting questions and sug-
gest further experiments in the area of biologic
approaches to vital pulp therapy. All of these experi-
ments have utilized clinically healthy teeth—that is, no
attempt was made to induce pulpitis specifically prior to
exposure and partial amputation of the vital pulp.
Clearly, it is important to attempt to determine the
degree and extent of existing pulpitis that can be suc-
cessfully treated. Currently, there is no precise definition
of "irreversible" pulpitis, nor are there definite clinical or
biochemical predictors of the extent of pulpitis or the
capacity of an inflamed pulp to recover. Discrepancies
exist between the signs and symptoms of pulpitis and
the histological evidence of pulpal inflammation
(Fitzgerald and Heys, 1991). In the absence of radi-
ographic evidence of periapical periodontitis, often few
clues are available to suggest the extent of pulpal pathol-
ogy. Alternatively, a frankly purulent pulp is generally
considered to be an irreversible condition. However, it is
possible that vital pulp remains deep to inflamed and
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even abscessed tissue. Theoretically,
removal of the diseased tissue to
expose the deeper vital pulp and
the application of a dentinogenic
molecule-therapeutic agent could
lead to preservation of a vital and
functional tooth. We are currently
attempting: (1) to model pulpitis
in vivo, (2) to develop diagnostic
criteria for qualitative and quanti-
tative assessment of pulpitis, (3)
to preserve the remaining pulp
therapeutically by inducing a pro-
tective layer of reparative dentin,
and (4) to correlate this outcome
to the nature and extent of the
inflammation. We are also attempt-
ing to determine the efficacy of
the OP-1/collagen carrier combi-
nation to repair periapical tissues
lost through disease or endodon-
tic manipulation. The opportunity
to induce controlled amounts of
reparative dentin anywhere in the
pulp chamber or root canal rein-
forces the need for the develop-
ment of direct assays of pulpal
inflammation and the determina-
tion of predictors of pulpal heal-
ing. Clinicians encountering an
exposed pulp could then diag-
nose the extent of disease and
accordingly prescribe direct vital
pulp therapy, root canal, or
extraction.
These studies suggest that
one or more of the known BMP
molecules can induce reparative
dentinogenesis in humans and
stimulate current efforts to devel-
op an approach to vital pulp ther-
apy based upon this biological
activity. It appears possible to
induce the formation of a mass of
reparative dentin therapeutically
in a uniquely useful way. In con-
trast to the pulpal response to
calcium hydroxide, BMPs stimu-
late the formation of a mass of
reparative dentin largely superfi-
cial to and not at the expense of
the pulp tissue. This tissue
appears to form first as a highly
vascular fibrous connective tis-
sue, perhaps resembling imma-
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ture dental pulp, that mineralizes over a period of time.
The size and shape of the reparative dentin are control-
lable since it replaces the OP-1/carrier complex
(Rutherford et al, 1993)—that is, the reparative dentin
may be induced to fill a dentinal defect to a desired size
and shape by extending the BMP/carrier complex super-
ficial (coronal) and lateral to the exposure site. The
dentinogenic response is dependent upon placing the
therapeutic complex on a vital dental pulp but appears
to be independent of the coronal extent of the vital tis-
sue, since, in non-human primates, reparative dentin
formed when OP-1 was placed at the orifice of the root
canals (Rutherford et al, 1994) as well as at the coronal
surface of the pulp chamber (Rutherford et al, 1993). By
six months, this tissue is comprised of about 95% miner-
alized matrix, and the pulpal surface is lined mostly by
quiescent-appearing cells (Rutherford et al, 1994), sug-
gesting that tissue formation had ceased. If these obser-
vations hold true for humans, the reliable therapeutic
induction of reparative dentinogenesis and preservation
of pulp vitality promise a conservative and more satis-
factory physiological clinical endpoint to the treatment
of vital yet substantially diseased or damaged dental
pulps than is currently available. Currently, such teeth
are either treated endodontically or extracted.
Optimum activity for the osteogenic proteins in vivo
(Wang et al, 1990; Sampath et al, 1992) is achieved by
combining them with a carrier molecule and implanta-
tion of the combination as a solid mass. In most of the
osteogenic protein research over the last decade, bone-
derived collagen has been utilized as the delivery matrix.
Whereas OP-1 has osteogenic activity when delivered in
vivo in solution, the use of the collagen-based carrier sub-
stantially enhances the activity. As described above, col-
lagen-based carriers were used to deliver BMP-2 and -4
(Nakashima, 1994) and OP-1 (Rutherford et al, 1993,
1994) in animal experiments of reparative dentin forma-
tion. However, no data have been published comparing
the effects of the collagen-based delivery systems with
those of other systems. The OP-1/collagen carrier used in
the monkey experiments is a powder which is dampened
with sterile saline and delivered with an amalgam carri-
er. It has a consistency resembling wet snow which has
advantages but is probably not adequate for all potential
clinical situations. There is a need to develop safe, effec-
tive, biocompatible, and biodegradable synthetic carriers
with different physical properties such as adhesiveness,
structural rigidity, and radiopacity.
It is clear that, at least in two animal models, recom-
binant human BMPs reliably induce a localized and pre-
determined amount of reparative dentin. The lack of
dentinogenic activity of TGF-pj and PDGF-BB suggests
that the pulp is restricted in its capacity to respond to
morphogens or growth factors. It is possible that there
are other genes, related or unrelated to the BMPs, specif-
ically involved in dentin formation. Any clues to the exis-
tence of such molecules should be pursued.
Our hypothesis is that adult dental pulps contain
cells responsive to at least some BMPs and that the inter-
action stimulates (either directly or indirectly) dental
pulp cells to proliferate, migrate, adhere (attach), and dif-
ferentiate to form reparative dentin. We subscribe to the
dictum that the pathway to understanding mechanisms
and developing therapeutics travels through structure.
However, no studies exist which comprehensively address
the fundamental biological processes leading to repara-
tive dentinogenesis. The cascade of molecular and cellu-
lar events central to this event has not been defined. The
regulation of odontoblast differentiation is not under-
stood. That a predetermined amount of reparative dentin
may be induced by OP-1 is clear. The compositon of this
tissue is not known; however, histologically, it appears to
be a mix of atubular and tubular dentin. It is important to
characterize this tissue and study the long-term viability
of irregular or atubular dentin. Atubular dentin may be
more caries-resistent, reduce post-operative sensitivity,
and provide an improved surface for dentin bonding.
Optimal reparative dentin may comprise a superficial
layer of atubular dentin with a deeper layer of tubular-like
dentin. Understanding regulation of odontoblast differ-
entiation is and should be a major goal of pulp biology.
Controlling the differentiation of odontoblasts should
lead to the capacity to regulate the type of reparative
dentin formed therapeutically, e.g., irregular or tubular
dentin. Therefore, from this perspective, as from others, it
is important to understand odontoblast differentiation
thoroughly, dentin formation specifically, and tissue
regeneration or healing in general. This information is
essential for a fuller understanding of future efforts in
direct biologic approaches to vital pulp therapy.
(IV) Reparative or Reactionary Dentinogenesis:
Transdentinal Approach
The ability to induce dentinogenesis in a controlled and
timely manner through a remaining wall of intact dentin
would be therapeutically useful. This concept of using
biologic agents to control pulpal response across an
existing layer of dentin, or a transdentinal approach, is a
relatively new approach to a long-recognized clinical
problem.
A layer of reparative dentin deep to the remaining
dentin has been hypothesized to afford the pulp tissue
an extra degree of protection from immediate and future
external irritants (Miller and Sassier, 1962; Tronstad,
1972; Cohen and Burns, 1991). This protection is pre-
sumably provided via two mechanisms: First, by increas-
ing the thickness of remaining dentin and reducing the
direct connection between tubules of the primary dentin
and the reparative dentin, the permeability of the dentin
to transportable irritants is greatly reduced (Pashley,
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1985, 1989). This reduced permeability severely limits
the volume and rate of delivery of irritants (i.e., dose of
irritants) to the dental pulp and thus provides the pulp
with additional protection. The thicker the dentin barrier
and the more restrictive the connection between the cut
dentin surface and the pulp via changes in the primary
dentin tubules and the tubules in the reparative dentin,
the better the barrier and thus the lower the exposure to
potential irritants. Second, the added thickness of dentin
increases the physical barrier between the
restoration/dentin interface and underlying vital dental
pulp. This extra thickness provides additional protection
from subsequent thermal and mechanical challenges
(Pashley, 1985, 1989). Similarly, a well-formed layer of
reparative dentin deposited directly against the dentin
tubules cut during cavity preparation could be instru-
mental in preventing subsequent pulpal disease. Since
maintaining the vitality of the dental pulp tissue is a pri-
mary objective in most restorative therapies, the timely
or early formation of a controlled and predictable
amount of reparative dentin immediately following
extensive dentin loss without overt pulp exposure would
be a desirable clinical goal.
This well-formed layer of reparative dentin deposit-
ed directly against the cut dentin must be limited in its
depth into the pulp and width along the primary dentin
interface. An unlimited reparative dentin response has
the potential of prematurely obliterating the pulp cham-
ber, thus compromising the healing potential of the
remaining pulp tissue (Torneck, 1990; Piattelli and Trisi,
1993), and reducing the chance of successful root canal
therapy (Cohen and Burns, 1991; Piattelli and Trisi,
1993).
CHARACTERISTICS OF AN IDEAL
TRANSDENTINAL TREATMENT
Reparative dentin induction should result in a controlled
stimulation of a natural reparative dentin barrier along
the dentin/pulp interface adjacent to the cut tubules.
Ideally, the stimulant should act rapidly, function
through intact cut dentin, be minimally inflammatory,
and result in a limited dentinogenic response.
Materials presently available to the dental practi-
tioner do not satisfy most of these criteria. However, sol-
uble dentin matrix proteins and OP-1 may potentially
satisfy these criteria. EDTA-soluble and collagenase-
released fractions of rabbit incisor dentin extracellular
matrix, but not control extracts, placed against freshly
cut dentin in adult ferret canines resulted in reactionary
dentin formation. The distinction between reactionary
dentin as opposed to reparative dentin formation was
made based on the observation that vitality of the origi-
nal odontoblasts was maintained throughout the study
(Smith et al, 1994). Although the study did not attempt to
identify which components extracted from dentin were
responsible for the observed response or whether a
dose-response relationship existed, it did demonstrate
that pre-existing odontoblasts were capable of respond-
ing to these components. Similarly, OP-1 in solution,
when applied to freshly cut dentin of non-human pri-
mate teeth, was associated with increased reactionary or
reparative dentin formation in a manner dependent
upon the concentration of OP-1 and the thickness of the
residual dentin wall (Rutherford et al, 1995). This study
did not address the question of the preservation of
odontoblast viability.
FUTURE DIRECTIONS
These results (Smith et al, 1994; Rutherford et al, 1995)
provide experimental support for the hypothetical poten-
tial of biologic agents to stimulate reactionary dentin
formation. Further study is needed to improve definition
of the action of these agents on mature odontoblasts
and their ability to satisfy the previously mentioned cri-
teria of a transdentinal treatment. Concurrent with these
studies should be the development of proper carrier
vehicles that will optimize clinical handling characteris-
tics and delivery through remaining intact dentin, which
poses particularly interesting challenges because of
dentin's ability to filter, buffer, and interact with agents
(Pashley, 1985, 1989).
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